Peptide Microarrays for Ebola Infection-Vaccine Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting filovirus infections and distinguishing between natural infection antibodies and vaccine-induced antibodies are cumbersome, expensive, and require high-level biocontainment, posing challenges for differential serodiagnosis and epidemiological investigations.
Innovation Solution
Development of specific and sensitive peptides that enable rapid serological detection of adaptive immune responses to a wide range of filoviruses, using platforms such as phage display, microarrays, ELISA, RIA, lateral flow, western blot, and bead-based assays.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If plaque reduction neutralization test (PRNT) is used for differential serodiagnosis, then measurement precision is improved, but device complexity and loss of time increase
Solution Approach 1:
The patent divides the filovirus detection system into multiple specific peptide components, each targeting distinct viral proteins (GP, VP40, VP35, etc.). This segmentation allows the complex neutralization test to be broken down into simpler peptide-based binding assays, maintaining diagnostic accuracy while reducing procedural complexity
Solution Approach 2:
The patent uses peptide copies or fragments of viral proteins as surrogate targets instead of requiring live virus or complete viral proteins. These peptide mimics retain the essential binding epitopes while simplifying the assay system, enabling differential diagnosis without the complexity of PRNT
2Measurement precision
If plaque reduction neutralization test (PRNT) is used for differential serodiagnosis, then measurement precision is improved, but loss of time increases
Solution Approach 1:
The patent pre-identifies and characterizes specific peptide sequences that bind to distinct viral proteins before the actual diagnostic test. This preliminary preparation of peptide libraries and binding assays eliminates the need for time-consuming live virus neutralization tests during epidemiological investigations
Solution Approach 2:
The patent replaces the mechanical and temporal complexity of plaque reduction neutralization testing with simpler peptide-antibody binding assays. The substitution of complex viral neutralization mechanisms with direct peptide-antibody interactions significantly reduces test duration while maintaining diagnostic precision
3Ease of operation
If conventional serological methods are used for filovirus detection, then ease of operation is improved, but measurement precision deteriorates due to cross-reactivity
Solution Approach 1:
The patent applies local quality by designing peptide sequences that target specific, conserved regions of filovirus proteins with unique binding epitopes. Each peptide is engineered to recognize a distinct viral component (e.g., GP for envelope proteins, VP40 for matrix proteins), providing localized specificity that prevents cross-reactivity between different filovirus species
Solution Approach 2:
The patent changes the molecular parameters of the detection system by using short, defined peptide sequences (typically 8-20 amino acids) with specific amino acid compositions. This parameter optimization creates distinct binding signatures for different filoviruses, enabling precise differentiation while maintaining assay simplicity
4Reliability
If high-level biocontainment is required for filovirus detection, then reliability is improved, but device complexity and loss of time increase
Solution Approach 1:
The patent uses peptide copies or synthetic analogs of viral proteins as detection targets instead of requiring live virus or intact viral components. These peptide surrogates maintain the essential epitopic information needed for reliable antibody detection while completely eliminating the need for high-level biocontainment facilities
Solution Approach 2:
The patent employs synthetic peptides that can be easily produced, disposed of, and replaced without biocontainment requirements. These disposable peptide reagents provide reliable detection while eliminating the complex infrastructure needed for live virus handling, making the system accessible to field laboratories
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptides allow for rapid, accurate, and cost-effective differential serological detection of filovirus infections, overcoming the limitations of existing methods and facilitating epidemiological studies and vaccine monitoring.
Implementation Method 1
peptides which are reactive with, and specific for one or more filovirus pathogens in Table 1 or EBOV vaccine
Data Source
AI summary
Peptides, platforms and methods for detecting antibody responses to filovirus infections, detecting antibody responses to EBOV infection, and detecting antibody responses to vaccination by EBOV vesicular stomatitis virus-based vaccine.